EN
HI
Parmax Pharma Chart
Parmax Pharma Share Key Metrics
Volume
30.00
Market Cap
11.52 CR
LTQ@LTP
20@30.65
ATP
30.67
Var Margin
40.34 %
Circuit Range
24.64-36.96
Delivery %
100 %
Value
920.10
ASM/GSM
No
Market Lot
1
Summary
At 10 Apr, 2026 | 15:09, Parmax Pharma share price stands at ₹30.65, showing a 0.15% -0.49 for the day. The stock’s intraday movement has stayed between ₹30.65 and ₹30.71, while on a 52-week basis it has fluctuated from ₹22.60 to ₹55.02.
In terms of trading activity, Parmax Pharma has recorded a volume of 30 shares, with a market capitalisation of ₹3741300. The stock’s Average Traded Price (ATP) stands at ₹3067, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 20,3065. The stock operates within a circuit range of ₹24.64-36.96, with a Value of ₹920.10. The Delivery Percentage for the day is 100%. Additionally, Parmax Pharma currently falls under the No framework, and trades with a market lot size of 1.
Parmax Pharma Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0
Sector P/E
62.26
Sector P/B
3.36
Sec. Div. Yield
0.58
Parmax Pharma Resistance and Support
Pivot 30.81
Resistance
First Resistance
30.82
Second Resistance
30.83
Third Resistance
30.84
Support
First Support
30.8
Second Support
30.79
Third Support
30.78
Parmax Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results |
| 2025-02-14 | Quarterly Results |
Parmax Pharma News
Parmax Pharma Ltd - 540359 - Appointment of Company Secretary and Compliance Officer
Parmax Pharma Ltd. has appointed Ms. Bhakti Aghera as its new Company Secretary and Compliance Officer (KMP). The appointment is effective March 24, 2026, bringing 6 years of corporate legal and secretarial experience to the role.
Mar 25 2026 11:03:00
Read More
About Parmax Pharma
NSE : 0
BSE : 540359
ISIN : INE240T01014
Parmax Pharma Limited was incorporated as a public limitedcompany on 02-11-1994 and the company received theCertificate of commencement of business from the Registrarof Companies Gujarat on 10-3-95. The Company is planningto set up a bulk drug plant to manufacture Amoxycillin trihydrade ampicillin tri hydrade Cephalexin mono hydrateand Nalidixic acid at Hadamtala Gondal. Dist Rajkot.
Parmax Pharma Management
| Name | Position |
|---|---|
| Dr. Umang Alkesh Gosalia | Managing Director |
| Ms. Ami R Shah | Independent Director |
Parmax Pharma Similar Stocks
Beryl Drugs Ltd.
24.33
-1.20 (4.70%)
Sharma East India Hospitals & Medical Research Ltd
98.00
-3.50 (3.45%)
Clinitech Laboratory Ltd.
36.00
1.00 (2.86%)
Norris Medicines Ltd.
14.50
0.26 (1.83%)
Soni Medicare Ltd.
0.00
0.00 (0.00%)
Starsource Multitrade Ltd.
122.80
1.95 (1.61%)
Colinz Laboratories Ltd.
47.85
1.56 (3.37%)
Broach Lifecare Hospital Ltd.
16.80
-0.20 (1.18%)
Unjha Formulations Ltd.
20.70
-0.33 (1.57%)
Parmax Pharma FAQs
The Buying Price of Parmax Pharma share is 30.65 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Parmax Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Parmax Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Parmax Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Parmax Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Parmax Pharma’s valuation compare Sector P/E, P/B which are 62.26 & 3.36 with sector averages, along with growth rates and financial metrics.
The Market Cap of Parmax Pharma is 11.52 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Parmax Pharma share price is 55.02 & 22.60. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Parmax Pharma belongs to the Healthcare sector.
